Rybelsus was the first oral glucagon-like peptide (GLP-1) receptor agonist treatment approved in the United States
By prioritizing quality, staying informed, and engaging in advocacy, compounding pharmacies can navigate these challenges and continue to provide patients with access to critical medications
Dorr, Izabelle Humes, David McCoy, Mohammed Adibuzzaman, Rumel Mahmood, Hannah Morgan-Cooper, Priya Desai, Shikha Yashwant Kothari, Anthony Sena, Clair Blacketer, Anna Ostropolets, Azza Shoaibi, Gowtham Rao, George Hripcsak, Patrick Ryan, Marc A
Layne Norton: I think there's a possibility, but I think based on the research I've seen, if it does exist, it's probably pretty small
Layne Norton: Now, sodium hydroxide, [01:01:00] again, the processing of these compounds through the processing turns into sodium and water, and then they just get rid of it